Reuters Health Report: July 5, 2017

Click to View in Browser Wednesday, July 5, 2017 Threat to HIV business spooks GlaxoSmithKline shares LONDON (Reuters) - The threat of new competition and potential loss of market share in GlaxoSmithKline's flagship HIV drug business unnerved investors in Britain's biggest drugmaker on Wednesday, sending the shares 1.5 percent lower in early trade. Proper tools may help prevent medicine errors at home (Reuters Health) - Providing parents with picture-based instructions - and with dosing tools that closely match the amount of medication needed - may help reduce cases of medication overdoses in children, researchers say. Australian class action suit filed against Johnson & Johnson over pelvic mesh SYDNEY (Reuters) - Australian women have brought a class-action case against Johnson & Johnson over complications arising from vaginal mesh implants - a lawsuit that follows many others in the United States, Canada and Europe. Active older adults getting more facial fractures (Reuters Health) - A growing number of older U.S. adults are suffering facial fractures during recreational activities like biking, gardening and playing sports, a recent study suggests. Mineral water can be calorie-free calcium source (Reuters Health) - Instead of drinking milk or taking supplements to get adequate amounts of calcium, calcium-rich mineral water is an equally good source, researchers say. Blood test by Britain's Angle detects ovarian cancer in study LONDON (Reuters) - British liquid biopsy company Angle said its Parsortix blood test had beaten current methods in identifying ovarian cancer, a breakthough that could help women receive the best possible outcome from surgery. Drugmaker Shire faces blood and guts battles on road to growth LONDON (Reuters) - Shire has come a long way since 1986, from selling calcium supplements from above a shop in southern England to becoming a poster child for a nimble global drugs firm, driven by deals and smart bets on specialty medicines. British ministers want post-Brexit drug regulation deal with EU LONDON (Reuters) - The British government sought to reassure drug companies and biotech firms on Monday by calling for continued co-operation with the European Union over drug regulation after Brexit. Crowded U.S. emergency depts tied to worse heart attack survival for blacks (Reuters Health) - When ambulances go on diversion, bypassing the nearest hospital because emergency rooms are overcrowded, black patients may be more likely to die following a heart attack than their white counterparts, a U.S. study suggests. Togo reports H5N1 bird flu in southern part of the country: OIE PARIS (Reuters) - Togo reported an outbreak of highly pathogenic H5N1 bird flu at a poultry farm in the southern part of the country, the Paris-based World Organisation for Animal Health (OIE) said on Monday, citing a report from the Togolese farm ministry. Related Video Chanel's "Parisienne" takes a stroll under the Eiffel Tower Eco microbeads producible on industrial scale, say UK scientists A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook